Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel metallotherapeutics, is announcing its selection by Life Sciences British Columbia (LSBC) for the 2023 'Company to Watch'

FibroBiologics, a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials,...

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present virtually at the upcoming Gilmartin Group Emerging...

The annual Linux Foundation Member Summit unites projects and organizations helping to advance open source technologies. SAN FRANCISCO, Sept. 14, 2023 /PRNewswire/ -- The Linux Foundation, the...

Harmonic's Cloud-Native Software Offers Up to 40% Improved Origin Performance for Video Streaming SAN JOSE, Calif., Sept. 14, 2023 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced a giant...